News and Event

A presentation about  Sydney Vital’s  successes in translational cancer research to date and  about its new plans moving forward

Meeting held on 14th December 2017 

A presentation about new approaches to managing thyroid cancer, adopting a highly personalized approach tailored to a patient’s specific risk. Our speaker panel included leading national thyroid cancer experts and they will discuss how treatment pathways are balanced to optimize patient outcomes:

• Prof Bruce Robinson: New medical therapies for high-risk thyroid cancers, offering new hope to these patients with previously poor outcomes.

• A/Prof Diana Learoyd: The importance of not over-treating low risk thyroid cancer, discussing how expert clinicians use patient-specific features to identify those that require minimal treatment.

• A/Prof Mark Sywak: Surgery for high risk thyroid cancer, identifying the need for careful pre-operative planning and the use of a multidiscplinary team approach.

• Dr Geoff Schembri: Modern trends in radioactive iodine treatment, using risk-adjusted dosing.

Panel Discussion held on 8th August 2017 

A presentation about support the goals of the following groups who are affiliated to a NSW Translational Cancer Research Centre (TCRC): Basic researchers, T2-T4 researchers
clinicians and community of practice members with an interest in the translational pipeline.

Workshop held on 17 May 2017